US equities |
SPCX $144.75 ▼-9.14% MU $856.49 ▼-6.26% NVDA $212.21 ▼-4.40% META $648.85 ▼-6.98% TSLA $374.58 ▼-3.08% AAPL $348.22 ▲+1.23% AMD $507.93 ▼-8.10% SNDK $1,260.93 ▼-8.51%
FinancialContent

Latest News about Akeso

Recent news which mentions Akeso

Summit, Akeso Report Lung Cancer Survival Boost With Ivonescimab, A Rival To Merck's Keytruda Multi-Billion Dollar Franchise, Says Analyst
Tickers MRK NEWS SMMT
Tags Price Target Market News Biotech
From Benzinga
Why Is Summit Therapeutics Stock Trading Higher On Monday?
Tickers BNTX MRK NEWS SMMT
Tags Health Care Trading Ideas Akeso
From Benzinga